Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pajewski

Showing results (161-170 of 196) with videos related to

Pageof 20
Sort By:
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 13, 2016
Characterizing Frailty Status in the Systolic Blood Pressure Intervention TrialNicholas M Pajewski, Jeff D Williamson, William B Applegate, et al.
JAMA Internal Medicine|October 12, 2020
Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical PracticePaul E Drawz, Anil Agarwal, Jamie P Dwyer, et al.
Contemporary Clinical Trials|April 2, 2023
Concordance between clinical outcomes in the Systolic Blood Pressure Intervention Trial and in the electronic health recordChi D Chu, Kristin M Lenoir, Nayanjot Kaur Rai, et al.
JAMA Network Open|July 14, 2022
Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT)Jordana B Cohen, Zachary A Marcum, Chong Zhang, et al.
Contemporary Clinical Trials|January 10, 2026
The long-term effectiveness of the anti-obesity medication phentermine (LEAP) trial: Rationale, design, and baseline characteristicsCaroline Blackwell Young, Emily Rives, Kimberly A Gudzune, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 20, 2021
Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and StructureManjula Kurella Tamura, Sarah Gaussoin, Nicholas M Pajewski, et al.
Hypertension (Dallas, Tex. : 1979)|July 2, 2019
Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEARTBharathi Upadhya, Michael V Rocco, Nicholas M Pajewski, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2016
Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure StudyPaul E Drawz, Nicholas M Pajewski, Jeffrey T Bates, et al.
Journal of the American Heart Association|July 17, 2019
Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINTLama Ghazi, Nicholas M Pajewski, Dena E Rifkin, et al.
Cell Reports. Medicine|June 21, 2023
Clinical trials in vascular cognitive impairment following SPRINT-MIND: An international perspectiveFanny M Elahi, Suvarna Alladi, Sandra E Black, et al.
Pageof 20

Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|January 13, 2016
Characterizing Frailty Status in the Systolic Blood Pressure Intervention TrialNicholas M Pajewski, Jeff D Williamson, William B Applegate, et al.
JAMA Internal Medicine|October 12, 2020
Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical PracticePaul E Drawz, Anil Agarwal, Jamie P Dwyer, et al.
Contemporary Clinical Trials|April 2, 2023
Concordance between clinical outcomes in the Systolic Blood Pressure Intervention Trial and in the electronic health recordChi D Chu, Kristin M Lenoir, Nayanjot Kaur Rai, et al.
JAMA Network Open|July 14, 2022
Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT)Jordana B Cohen, Zachary A Marcum, Chong Zhang, et al.
Contemporary Clinical Trials|January 10, 2026
The long-term effectiveness of the anti-obesity medication phentermine (LEAP) trial: Rationale, design, and baseline characteristicsCaroline Blackwell Young, Emily Rives, Kimberly A Gudzune, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 20, 2021
Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and StructureManjula Kurella Tamura, Sarah Gaussoin, Nicholas M Pajewski, et al.
Hypertension (Dallas, Tex. : 1979)|July 2, 2019
Effect of Intensive Blood Pressure Reduction on Left Ventricular Mass, Structure, Function, and Fibrosis in the SPRINT-HEARTBharathi Upadhya, Michael V Rocco, Nicholas M Pajewski, et al.
Hypertension (Dallas, Tex. : 1979)|November 17, 2016
Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure StudyPaul E Drawz, Nicholas M Pajewski, Jeffrey T Bates, et al.
Journal of the American Heart Association|July 17, 2019
Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINTLama Ghazi, Nicholas M Pajewski, Dena E Rifkin, et al.
Cell Reports. Medicine|June 21, 2023
Clinical trials in vascular cognitive impairment following SPRINT-MIND: An international perspectiveFanny M Elahi, Suvarna Alladi, Sandra E Black, et al.
Pageof 20